Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Solomon

Showing results (1331-1340 of 1,388) with videos related to

Pageof 139
Sort By:
JTO Clinical and Research Reports|January 29, 2025
Durvalumab, Tremelimumab, and Platinum Chemotherapy in <i>EGFR</i> Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)Chee Khoon Lee, Bin-Chi Liao, Shalini Subramaniam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosisKarlo Toljan, Lynn Daboul, Praneeta Raza, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 13, 2023
A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosisLynn Daboul, Carly M O'Donnell, Moein Amin, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: global health considerationsJorge Correale, Andrew J Solomon, Jeffrey A Cohen, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 16, 2024
Multicenter validation of automated detection of paramagnetic rim lesions on brain MRI in multiple sclerosisLuyun Chen, Zheng Ren, Kelly A Clark, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 22, 2025
Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter StudyMelissa Lynne Martin, Quy Cao, Elaina Luskin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 21, 2026
Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosisKarlo Toljan, Brian Renner, Lynn Daboul, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
JCO Precision Oncology|February 9, 2022
<i>EGFR</i> Genotyping of Matched Urine, Plasma, and Tumor Tissue in Patients With Non-Small-Cell Lung Cancer Treated With Rociletinib, an <i>EGFR</i> Tyrosine Kinase InhibitorJonathan W Goldman, Chris Karlovich, Lecia V Sequist, et al.
Imaging Neuroscience (Cambridge, Mass.)|October 15, 2025
Automated segmentation of multiple sclerosis lesions, paramagnetic rims, and central vein sign on MRI provides reliable diagnostic biomarkersFengling Hu, Zheng Ren, Luyun Chen, et al.
Pageof 139

Showing results (1331-1340 of 1,388) with videos related to

Sort By:
Pageof 139
JTO Clinical and Research Reports|January 29, 2025
Durvalumab, Tremelimumab, and Platinum Chemotherapy in <i>EGFR</i> Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)Chee Khoon Lee, Bin-Chi Liao, Shalini Subramaniam, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosisKarlo Toljan, Lynn Daboul, Praneeta Raza, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 13, 2023
A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosisLynn Daboul, Carly M O'Donnell, Moein Amin, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: global health considerationsJorge Correale, Andrew J Solomon, Jeffrey A Cohen, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|October 16, 2024
Multicenter validation of automated detection of paramagnetic rim lesions on brain MRI in multiple sclerosisLuyun Chen, Zheng Ren, Kelly A Clark, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 22, 2025
Reliability of Central Vein Sign Imaging With 3T FLAIR* in a Multicenter StudyMelissa Lynne Martin, Quy Cao, Elaina Luskin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 21, 2026
Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosisKarlo Toljan, Brian Renner, Lynn Daboul, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J Solomon, Sonye K Danoff, Felix A Woodhead, et al.
JCO Precision Oncology|February 9, 2022
<i>EGFR</i> Genotyping of Matched Urine, Plasma, and Tumor Tissue in Patients With Non-Small-Cell Lung Cancer Treated With Rociletinib, an <i>EGFR</i> Tyrosine Kinase InhibitorJonathan W Goldman, Chris Karlovich, Lecia V Sequist, et al.
Imaging Neuroscience (Cambridge, Mass.)|October 15, 2025
Automated segmentation of multiple sclerosis lesions, paramagnetic rims, and central vein sign on MRI provides reliable diagnostic biomarkersFengling Hu, Zheng Ren, Luyun Chen, et al.
Pageof 139